|
Jerry Hribar serves as Scientific Director of MBR’s Structure Analysis group. His responsibilities include overseeing a team that specializes in structure identification of small molecule metabolites and impurities using mass spectrometry and other sophisticated instruments.Jerry has more than 32 years of experience in the pharmaceutical industry interpreting mass spectral data based on reaction pathways. His experience spans drug discovery, development, metabolism, manufacturing and marketing products. Prior to MBR, Jerry managed the Structure Identification Laboratory at Pfizer/Pharmacia (formerly Searle/Monsanto). He also was director of the NIH High Resolution Mass Spectrometry Facility at Cornell University.Jerry received his Ph.D. in organic chemistry and mass spectrometry from Wayne State University. | 